Biologics Production Manufacturing Insurance: Safeguarding Your Pharmaceutical Innovation
Introduction: The Complex World of Biologics Manufacturing
Biologics manufacturing represents the cutting edge o…






Pharmaceutical and life-sciences businesses often talk about “liability insurance” as if it’s one thing. In reality, the industry typically relies on different policies to cover different loss pathways. Product Liability is mainly about third-party injury or damage caused by products after supply. Product Recall/Withdrawal is about the operational cost of removing product from the market (even if nobody is injured). Clinical Trial insurance is designed to protect sponsors and others involved in clinical studies if trial participants are injured or allege harm related to the investigational product or trial procedures.
Confusion between these covers is one of the most common causes of uninsured losses. A business may buy product liability and assume it includes recall costs. Or a business may begin clinical activity and assume product liability automatically covers investigational trials. The result can be gaps at the worst possible time: when regulators, customers or trial sites require immediate response.
This page explains what each policy is designed to do, what it typically covers, where exclusions or limitations commonly apply, and how manufacturers and CDMOs can structure an integrated programme.
Think of the three covers like this:
The same incident can touch more than one policy. For example, a contamination event might lead to a withdrawal (recall costs), and later a patient claim (product liability). Or an issue with an investigational product might lead to trial participant allegations (clinical trial), plus reputational and logistics costs that fall outside standard liability.
Product liability insurance is designed to protect your business if a third party alleges that a product you manufactured or supplied caused bodily injury, illness, death, or property damage. For pharmaceutical manufacturers, this can involve complex causation, large legal costs, and high severity exposures — especially for products supplied internationally.
Product liability is typically triggered by a claim (or potential claim) from a third party. It commonly covers legal defence costs, settlement costs and damages where you are legally liable. It may also include “completed operations” depending on policy structure, and it may interact with contractual indemnities within supply agreements.
Product liability is essential — but it is not designed to pay for the internal operational cost of removing product from the supply chain. That’s the job of recall/withdrawal cover.
Underwriting focus often includes product types, territories (EU/US), batch values, distribution model, quality controls, complaint history and any prior recalls.
Product liability is powerful when the scenario is “harm claim”. If the scenario is “quality issue with no injury”, product liability may not pay the costs you care about most.
Recall (or withdrawal) insurance is designed to cover the operational and logistical costs of removing product from the supply chain when there is a known or suspected defect, contamination, mislabelling, or other quality issue that makes the product unsafe, non-compliant or unfit for intended use. This can be required even when no one has been harmed.
In pharmaceuticals, withdrawals can arise from deviations, stability concerns, packaging errors, data integrity issues, or GMP findings that undermine confidence in product release. The cost is often dominated by logistics: identifying affected batches, contacting customers, arranging returns, managing quarantine, disposal/destruction, and documenting the process.
Importantly, recall/withdrawal is a “first-party cost” cover: it is about the cost you incur to act responsibly and protect patients, customers, and licences.
Cover triggers and sub-limits vary. Some policies require regulatory order; others respond to voluntary withdrawals when there is credible risk.
The right structure depends on your distribution model and how quickly you could locate and retrieve affected batches.
Clinical trial insurance is designed to cover liabilities arising from clinical research — typically relating to injury to trial participants or allegations of harm connected to the investigational medicinal product (IMP) or trial procedures. It is commonly required by trial sites, ethics committees, CROs, and sponsors, and may be needed even for early-stage trials with small participant numbers.
For manufacturers and life-sciences companies, the clinical trial exposure can arise when you act as sponsor, co-sponsor, manufacturer of an IMP, or where you have contractual responsibility connected to trial supply. Policies are usually structured to reflect study protocol, territories, phases (I–IV), and who is covered (sponsor, investigators, sites).
Clinical trial cover is not a “recall” policy — it does not typically pay for the cost of withdrawing product from general commercial markets — and it is not always interchangeable with product liability. It is a specialist liability product aligned to the specific risk environment of clinical research.
Requirements vary by country and trial design. Policies are usually arranged for a specific trial or a portfolio programme, depending on your pipeline.
If your company is moving from development to clinical activity, it’s worth reviewing insurance early — clinical trial requirements can be time-sensitive in study start-up.
Many life-sciences businesses need more than one of these policies at the same time. A CDMO might need product liability for commercial supply, recall/withdrawal for first-party logistics, and clinical trial cover for investigational batches if they participate in IMP manufacturing or sponsor activity.
The goal is to avoid overlaps and gaps. Overlaps can create disputes about which insurer pays. Gaps create uninsured costs. The best approach is to map activities and allocate them cleanly: commercial product supply vs investigational trial supply vs operational withdrawal costs.
If you manufacture both commercial and investigational product on the same site, ensure the business description and policy schedules reflect both activities accurately.
These details are where disputes occur. Getting them right at placement stage is far easier than arguing after an incident.
“We assumed product liability covered recall and trial exposures — it didn’t. Aligning the three policies gave us clarity and confidence under contract and regulator pressure.”
Commercial Director, Life Sciences BusinessDoes product liability insurance cover product recall costs?
When do I need clinical trial insurance?
Can a CDMO need all three covers at the same time?
Is clinical trial insurance the same as product liability?
What limits are typical for product liability, recall and clinical trial cover?
How do I get a quote for the right mix of these covers?
Biologics manufacturing represents the cutting edge o…
The oral medication manufactur…
In the highly regulated and precision-driven world of tablet and capsule production, comprehensive insurance is not ju…
Published: September 2025 | Insure24 Pharmaceutical Insurance Specialists
The pharmaceutical manufacturing…
The monoclonal an…
Published: September 2025 | Insure24 Commercial Insurance Guides